Kunming Longjin Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Kunming Longjin Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Kunming Longjin Pharmaceutical Co Ltd (002750) has a cash flow conversion efficiency ratio of -0.011x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-6.69 Million ≈ $-978.60K USD) by net assets (CN¥582.16 Million ≈ $85.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Kunming Longjin Pharmaceutical Co Ltd (2011–2024)
Cash flow conversion efficiency of Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2024. This chart illustrates how Kunming Longjin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Kunming Longjin Pharmaceutical Co Ltd (002750) share price today for real-time trading data and today's change.
Kunming Longjin Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Kunming Longjin Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Kunming Longjin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kunming Longjin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 002750 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Forward Graphic Enterprise Co Ltd
TWO:8906
|
-0.044x |
|
Generations Bancorp NY Inc
NASDAQ:GBNY
|
0.047x |
|
NuriFlex Co.Ltd
KQ:040160
|
-0.001x |
|
Mind Technology Inc
NASDAQ:MIND
|
0.022x |
|
RTG Mining Inc
TO:RTG
|
0.000x |
|
Planet Image International Limited Class A Ordinary Shares
NASDAQ:YIBO
|
-0.077x |
|
Hudson Global Inc
NASDAQ:HSON
|
0.003x |
|
SBH Marine Holdings Berhad
KLSE:0300
|
-0.034x |
Annual Cash Flow Conversion Efficiency for Kunming Longjin Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2024. Review cash generation quality of Kunming Longjin Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥494.21 Million ≈ $72.32 Million |
CN¥-34.24 Million ≈ $-5.01 Million |
-0.069x | +4.52% |
| 2023-12-31 | CN¥541.13 Million ≈ $79.18 Million |
CN¥-39.26 Million ≈ $-5.75 Million |
-0.073x | -203.80% |
| 2022-12-31 | CN¥604.77 Million ≈ $88.50 Million |
CN¥-14.44 Million ≈ $-2.11 Million |
-0.024x | -9.42% |
| 2021-12-31 | CN¥678.29 Million ≈ $99.26 Million |
CN¥-14.80 Million ≈ $-2.17 Million |
-0.022x | -126.96% |
| 2020-12-31 | CN¥704.71 Million ≈ $103.12 Million |
CN¥-6.78 Million ≈ $-991.68K |
-0.010x | -258.38% |
| 2019-12-31 | CN¥665.89 Million ≈ $97.44 Million |
CN¥4.04 Million ≈ $591.66K |
0.006x | -87.44% |
| 2018-12-31 | CN¥655.93 Million ≈ $95.98 Million |
CN¥31.70 Million ≈ $4.64 Million |
0.048x | -46.27% |
| 2017-12-31 | CN¥645.54 Million ≈ $94.46 Million |
CN¥58.06 Million ≈ $8.50 Million |
0.090x | -42.15% |
| 2016-12-31 | CN¥670.46 Million ≈ $98.11 Million |
CN¥104.24 Million ≈ $15.25 Million |
0.155x | +32.78% |
| 2015-12-31 | CN¥599.41 Million ≈ $87.71 Million |
CN¥70.19 Million ≈ $10.27 Million |
0.117x | -52.34% |
| 2014-12-31 | CN¥285.57 Million ≈ $41.79 Million |
CN¥70.16 Million ≈ $10.27 Million |
0.246x | -30.30% |
| 2013-12-31 | CN¥302.00 Million ≈ $44.19 Million |
CN¥106.46 Million ≈ $15.58 Million |
0.353x | -12.24% |
| 2012-12-31 | CN¥226.94 Million ≈ $33.21 Million |
CN¥91.16 Million ≈ $13.34 Million |
0.402x | -1.16% |
| 2011-12-31 | CN¥186.74 Million ≈ $27.33 Million |
CN¥75.90 Million ≈ $11.11 Million |
0.406x | -- |
About Kunming Longjin Pharmaceutical Co Ltd
Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. The company offers medicines in the areas of cardiovascular and cerebrovascular, digestive system, vitamin, minerals and enteral nutrition, and immunology, as well as first aid kits; extracts of natural plants, such as breviscapine; and industrial… Read more